Actively Recruiting
Defining Novel Strategies for the Diagnosis and Treatment of Intraoperative Air Leaks Using an Ex-Vivo Human Lung Model
Led by Centre hospitalier de l'Université de Montréal (CHUM) · Updated on 2026-03-18
200
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying ways to detect, measure, and treat air leaks that happen during lung surgery. The goal is to reduce complications, problems after surgery, and hospital stays for patients who have lung tissue removed. This research uses human lungs removed during transplant surgeries to create a stable and effective lung model for testing these methods. The lungs from transplant patients will be kept in a special acrylic box at 37 degrees Celsius and mechanically ventilated through an inserted tube to simulate breathing. Different procedures will be performed, including creating air leaks by stapling or cutting the lung tissue. A novel bio-adhesive sealant will be applied to these leaks to test its ability to seal them. The seal will be checked using gas and water techniques, and air leaks will be measured using an automated drainage system. Participants will not be directly involved since the study uses removed lungs. Researchers will perform multiple procedures on the lungs, collect tissue samples, and take images to find the best model settings. Lung tissue temperature, blood vessel pressure, and other factors will be monitored. The main outcomes measured are detecting and localizing air leaks and reducing their size by 80% with the bio sealant. The study follows a 48-month timeline for these assessments, with all lung specimens processed according to transplant protocols after testing.
CONDITIONS
Brief Title
Air Leak Detection and Treatment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients undergoing lung transplant surgery
- Organ donor ineligible to donate lungs
You will not qualify if you...
- Healthy individuals
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to several hours during ex-vivo lung testing
Participants' lungs obtained after transplantation surgery are prepared and mechanically ventilated in an ex-vivo model for diagnostic testing including endoscopic and RAB procedures.
1 visit (ex-vivo lung model testing session)
Duration - Up to 48 months
The lungs undergo repeated air leak testing and ventilation to assess the stability and effectiveness of the novel bio sealant over time.
No participant visits; monitoring occurs during the study period
Trial Site Locations
Total: 1 location
1
CHUM
Montreal, Quebec, Canada, H2X 0A9
Actively Recruiting
Research Team
M
Moishe Liberman, MD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here